Large-body radiation doses following radioiodine therapy
- 1 November 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 23 (11) , 1091-1097
- https://doi.org/10.1097/00006231-200211000-00009
Abstract
In accordance with the recommendations of the International Radiological Protection Commission, the current maximum acceptable radiation dose limits for members of the public have been reduced to 1 mSv in the United States, Canada, and European Union countries including the United Kingdom. This has had a significant impact on radiation protection guidelines for contacts of patients treated with 131I. Many previous recommendations have relied upon models which may overestimate dose rates at short distances. We therefore undertook measurements of 131I dose rates using adult and infant phantoms that more accurately reflected true geometry. Effective dose calculations and patient contact restrictions were then derived from these direct dose measurements. Doses received by the adult phantom were measured at three distances (contact, 1.0 m, 2.0 m) and doses received by the infant phantom were measured at contact in two orientations (adult cradling infant over shoulder and at waist). The doses measured were significantly lower than previously predicted for the adult and infant phantom. Our measurements suggest that patient contact restrictions could be made less stringent than those currently in widespread use.Keywords
This publication has 8 references indexed in Scilit:
- Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid CarcinomaPublished by American Medical Association (AMA) ,2000
- Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Calculation of radiation exposures from patients to whom radioactive materials have been administeredPhysics in Medicine & Biology, 1998
- Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisNuclear Medicine Communications, 1993
- Analysis of radiation doses received by the public from 131I treatment of thyrotoxic outpatientsNuclear Medicine Communications, 1993
- Radiological protection guidance for radioactive patients — new data for therapeutic 131 INuclear Medicine Communications, 1991
- Radioiodine therapy to out-patients—the radiation hazardThe British Journal of Radiology, 1971